Compare FOFO & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOFO | CCM |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | Hong Kong | China |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2M | 19.0M |
| IPO Year | 2025 | 2009 |
| Metric | FOFO | CCM |
|---|---|---|
| Price | $2.70 | $4.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.0K | ★ 55.6K |
| Earning Date | 03-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.09 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.75 | $3.18 |
| 52 Week High | $68.00 | $6.98 |
| Indicator | FOFO | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 52.60 |
| Support Level | $2.33 | $4.41 |
| Resistance Level | $2.88 | $5.38 |
| Average True Range (ATR) | 0.19 | 0.55 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 77.36 | 44.66 |
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.